
|Articles|June 1, 2019
Sustained-release implant promising for long-term IOP reduction
Author(s)Julianne Mobilian
E. Randy Craven, MD, shares results from a phase 1/2 study involving an intracameral bimatoprost sustained-release implant.
Advertisement
RELATED:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5
2
Q&A: Nadia Waheed on the role of OCT in the future of ophthalmology
3
Researchers assess atropine and cyclopentolate for detecting premyopia in young children
4
Q&A: Patricio Schlottmann discusses results of AVONELLE-X faricimab extension trial
5